Back
Goldman Sachs S&P 500 Premium Income ETF Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Buy
66
GPIX
Goldman Sachs S&P 500 Premium Income ETF
Last Price:
$52.96
Seasonality Move:
-0.32%
Sell
43
VKTX
Viking Therapeutics, Inc.
Last Price:
$35.40
Seasonality Move:
33.2%
Buy
66
Goldman Sachs S&P 500 Premium Income ETF (GPIX)
is a Buy
Is Goldman Sachs S&P 500 Premium Income ETF a Buy, Sell or Hold?
-
The current Goldman Sachs S&P 500 Premium Income ETF [GPIX] share price is $52.96. The Score for GPIX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
GPIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $35.40. The Score for VKTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPIX Stock Price Chart
What is Goldman Sachs S&P 500 Premium Income ETF's stock price today?
-
The Goldman Sachs S&P 500 Premium Income ETF share price today is $52.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $35.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight buying pressure.
GPIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 57.49 | Buy |
| Chaikin Money Flow: | 469967 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.69 - 52.87) | Buy |
| Bollinger Bands (100): | (50.97 - 52.63) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.75 | Buy |
| Relative Strength Index (14 RSI): | 47.56 | Sell |
| Chaikin Money Flow: | 331195 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.61 - 37.59) | Sell |
| Bollinger Bands (100): | (27.52 - 37.88) | Buy |
GPIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.51 | Buy |
| 20-day SMA: | 52.53 | Buy |
| 50-day SMA: | 52.35 | Buy |
| 200-day SMA: | 49.68 | Buy |
| 8-day EMA: | 52.55 | Buy |
| 20-day EMA: | 52.46 | Buy |
| 50-day EMA: | 52.24 | Buy |
| 200-day EMA: | 50.59 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.63 | Sell |
| 20-day SMA: | 36.1 | Sell |
| 50-day SMA: | 36 | Sell |
| 200-day SMA: | 30.21 | Buy |
| 8-day EMA: | 22.1 | Buy |
| 20-day EMA: | 11.47 | Buy |
| 50-day EMA: | 5.14 | Buy |
| 200-day EMA: | 1.36 | Buy |
Goldman Sachs S&P 500 Premium Income ETF Earnings Growth & GPIX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
Goldman Sachs S&P 500 Premium Income ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||